These changes result in a decrease in the protective effects of the ACE2/ANG1–7/MasR axis and favor the detrimental effect of relatively underregulated ANG II activity and possibly leading to a higher incidence of myocardial infarction in appropriately predisposed patients. The gene discussed is MAS1L; the disease is myocardial infarction.